Other Announcements

Requests for Proposals

Request for Applications: 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction
The National Institute on Drug Abuse (NIDA) Translational Avant-Garde Award is designed to support dedicated and talented basic and/or clinical researchers with the vision, drive and expertise necessary to translate research discoveries into medications for the treatment of diseases of addiction. Through this funding opportunity announcement, NIDA is committed to making significant advances in the development of safe and efficacious products for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use or abuse. Applications are being accepted online from June 2-July 2, 2010. Click here to read more.

top

Other Announcements

FDA to launch stakeholder listening series
The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) will launch a Stakeholder Listening Series in 2010. The Stakeholder Listening Series will help the CTP to more effectively implement its authority over tobacco marketing and sales by taking full advantage of the knowledge, ideas, feedback, and suggestions from all communities interested in and affected by tobacco product regulation. The listening sessions will focus on a variety of topics, and will consist of presentations from topic experts and the FDA, followed by facilitated discussions among participants. Over the coming year, multiple listening sessions will be held across the country for public health groups, tobacco industry stakeholders, academic organizations, and organizations representing specific populations. FDA will post a schedule of the listening sessions in the next few months. For a list of potential topics and stakeholders, or to sign up for an email notification service, click here.

FDA Center for Tobacco Products selects Dr. David L. Ashley as first Director for the Office of Science
The Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA) has announced that Dr. David L. Ashley (CAPT, USPHS) will join the CTP in June as its first Director for the Office of Science. He will be responsible for ensuring that the CTP’s regulatory activities are driven by science. Dr. Ashley began his career as a bench scientist, and is currently the chief of the CDC’s Emergency Response and Air Toxicants Branch, one of the agency’s largest branches. He is also part of the World Health Organization (WHO) Study Group on Tobacco Product Regulation and serves as chair of WHO’s Tobacco Laboratory Network. Click here to read more.

Tobacco Law Center becomes Public Health Law Center
The Tobacco Law Center, home to the Tobacco Control Legal Consortium, is now the Public Health Law Center, reflecting the idea that policy and law are crucial to public health. The legal skills and expertise used in tobacco control will now also be applied to other health priorities, such as childhood obesity, worker health, and product regulation. The Robert Wood Johnson Foundation has also asked the Public Health Law Center to create and coordinate a technical assistance network of legal experts to support the legal resources of local and state governments. Visit the Public Health Law Center website to learn more.

top

Back to Table of Contents